Frank Pallone actually said...

I think it is unfortunate that after 5 years, I think we should be closer on implementation on what I consider a very critical component.

the imbalance of inspection requirements between U.S. and foreign manufacturing facilities creates an uneven playing field for pharmaceutica...

Thank you. Now, would it be helpful to have additional resources to conduct more foreign inspections of brand facilities?

As you know, Mr. Dingell, Ms. DeGette, myself, and Mr. Waxman have introduced the Drug Safety Enhancement Act that gives the FDA authorities...